Fig. S1. Ki et al .,

Sep 09, 2014

10 likes | 87 Views

Amino acid sequences of the variable heavy chain of clec14a-CTLD IgGs. Amino acid sequences of the variable light chain of clec14a-CTLD IgGs. Fig. S1. Ki et al .,.

Share Presentation

Embed Code

Link

fig
variable heavy chain
variable light chain

serge

Download Presentation

Fig. S1. Ki et al .,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Amino acid sequences of the variable heavy chain of clec14a-CTLD IgGs Amino acid sequences of the variable light chain of clec14a-CTLD IgGs Fig. S1. Ki et al.,

Fig. S1

Fig. S1. Fig. S1 Representative histologic image of CCl 4 -induced cirrhotic liver. Azan-Mallory staining; original magnification x50. Fig. S2. Cirrhosis. Normal. IL-1 b. IL-8. TNF- a. TGF- b. PRL21. Fig. S2 Cytokine expression levels in the liver of ci rrhotic rats.

174 views • 2 slides

Fig. S1

a. b. 2.5. 7. 6. 2.0. 5. 1.5. 4. c ell mortality ratio (%). r elative cell number. 3. 1.0. 2. 0 .5. 1. 0. 0. CN 0.1 0.5 1 5 10 20 30. Sal ( m M ). CN 0.1 0.5 1 5 10 20 30. Sal ( m M ). c. 8. **. 6. Alizarin red S staining

167 views • 4 slides

Fig S1

Fig S1.

139 views • 3 slides

Tholen et al ., Sup . Fig. S1

Tholen et al ., Sup . Fig. S1. Tholen et al ., Sup . Fig. S2. A. B. C. Tholen et al ., Sup . Fig. S3. A. B. No . of proteins identified. No . of proteins identified. C. D. No . of proteins identified. No . of proteins identified. Tholen et al ., Sup . Fig. S4.

132 views • 6 slides

Fig S1

Fig S1. A). B). pET-opTAL. pET -TAL. M 3 4. kDa. kDa. M 1 2. 95. 95. 72. 72. 55. TAL. opTAL. 55. 43. 43. *. 34. 34. Fig S2. A). B). pET-opT5. pET-T5. M 3 4. M 1 2. kDa. kDa. 95. 95. 72. 72. Sam5(59kDa). Sam5 (59kDa). 55.

163 views • 4 slides

Fig. S1; Ritter et al. 2010

Relative induction of p-Erk1. Relative induction of p-IRAK1. Relative induction of p-RAF. Relative induction of p-Erk2. Relative induction of p-MKK6/3. Relative induction of p-MEK1/2. Fig. S1; Ritter et al. 2010. Relative induction of p-ELK. Relative induction of p-RSK.

179 views • 3 slides

Fig. S1

3.74%. 3.54%. 45.60%. 41.22%. 3.54%. 3.74%. 47.21%. 43.34%. 4.35%. 5.15%. 2.01%. 3.00%. 4.35%. 5.15%. 33.84%. 34.73%. ROS dye added after trypsinization. ROS dye added before trypsinization. Percentage of ethidium fluorescence positive cells (O 2 .- production). Control. No GP.

253 views • 11 slides

Miao et al., Fig. S1

Miao et al., Fig. S1.

148 views • 7 slides

Supplemental Fig. S1 Awano et al

*. 0.10. D272NRNase R. 0.08. D280NRNase R. D. CsdA-. C. 0.06. Fraction unwound. 0.04. 0.02. 0.00. 0. 5. 10. 15. 20. 25. Time (min). Supplemental Fig. S1 Awano et al. A. CsdA- D C. RNase R-WT. D272NRNase R. D278NRNase R. D280NRNase R. Time (min).

116 views • 2 slides

Pathiraja, et al. Supp. Fig. S1

Pathiraja, et al. Supp. Fig. S1. TRIM24 expression in TCGA BRCA. A. B. Top 30% vs. Bottom 70%. p-value : 1.32e-07. log2 FC (Invasive carcinoma/normal). p-value : 1.46e-08; Odds ratio : 0.43. p-value : 0.047; odds ratio : 1.40. p-value : 3.8e-04; Odds ratio : 1.98. Paired Samples.

185 views • 6 slides

Fig. S1

Fig. S1. WT Tg. Hsp90 Hsp70/72 HSPA12B * Hsp60 Hsp25  BC  -Tubulin. HSPA12B. PCAM-1. Merge. HSPA12B. PCAM-1. Merge. Fig.S2A. Fig.S2B. WT Tg. Baseline. 1 week post-sham. 4 weeks post-sham. Fig. S3. WT Tg. Fig. S4.

257 views • 11 slides

Fig. S1. Weng et al.

Relative ELISA titer (%). Fig. S1. Weng et al. 1b 1a 2a. HCR6 RdRp. H77 RdRp. JFH1RdRp. GST-L245A/I253A. A242C/S244D. A238S/Q248E. J6CF RdRpwt. Protein marker. RMT RdRpwt. Con1 RdRpwt. NN RdRpwt. A242C. S244D.

142 views • 5 slides

Fig. S1. (Zhu et al.)

Day 6 T cells. Donor-1. Donor-2. - + - +. - + - +. Roc-A:. - - + +. - - + +. PMA/iono.:. p-JNK-1 -. p-JNK-2 -. JNK-1 -. Fig. S1. (Zhu et al.).

90 views • 1 slides

Fig. S1 . Lee. et. al.

118 views • 1 slides

Fig. S1 . Okubo et al.

a. b. c. d. e. g. f. h. i. k. j. l. Fig. S1 . Okubo et al. a. c. b. d. e. g. f. h. i. j. k. l. Fig. S2 . Okubo et al. a. c. b. d. e. g. f. h. i. j. k. l. Fig. S3 . Okubo et al. a. d. b. c. g. h. e. f. k. i. j. l. Fig. S4 . Okubo et al. a. c. d.

135 views • 6 slides

Supplemental Fig. S1. Nishimura et al. PMB

Supplemental Fig. S1. Nishimura et al. PMB. A. RlemMT1. B. RlemMT2.

87 views • 1 slides

Fig. S1

Fig. S1. 0,4. 0,2. 0. -0,2. RIS. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. -1,6. Strains. 0,4. 0,2. 0. -0,2. ALE. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. Strains. 0,4. 0,2. 0. -0,2. IBA. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. Strains.

116 views • 4 slides

[Fig. S1]

[Fig. S1]. S 1 2 3 4 5 6 7 8 9. S 1. KDa. KDa. 250. 200. 150. 116. 100. 97. 75. (A). (B). 66. 50. 45. 37. 25. 20.

91 views • 1 slides

Teng et al. Fig. S1

Teng et al. Fig. S1. D ssa1. D dnm1. D ssa2. D ssa1. D dnm1. D ssa2.

90 views • 1 slides

Fig. S1

Fig. S1. A. B. **. Relative total length. Relative total length. **. *. *. control. 100ng/ml. 200ng/ml. 400ng/ml. HDFNs. HUVECs. HDFNs. HUVECs. CM. Transwell. TIMP-1. C. D. **. Relative total length. Relative total length. **. control. Con siRNA. TIMP-1 siRNA.

122 views • 3 slides

Supplemental Fig. S1 Koma et al.

M. M. CFE. CFE. PF. PF. 114,000. 114,000. 84,700. 84,700. 47,300. 47,300. 31,300. 31,300. MJ1008. TTE0933. TTHA0124. M. CFE. PF. (Da). (Da). (Da). 114,000. 84,700. 47,300. 31,300. Supplemental Fig. S1 Koma et al.

147 views • 1 slides

More Related